This article only represents the author's own views.
Surging investments in AI data centers and high-end medical equipment are boosting global demand for precision components. That’s providing a big business opportunity for Impro Precision Industries Ltd. (1286.HK), which built its original business on investment casting and precision machining, but more recently has been moving into the aerospace, energy and medical fields. To assist that effort, the company has launched a relatively large share sale, earmarking the funds for capacity expansion and boosting its efforts at the higher end of the market.
Last week the company announced plans to sell up to 60 million new shares for HK$9.10 each, representing a discount of 13.6% to its closing price before a trading halt. The placement will raise approximately HK$539 million ($69 million), which will be used to expand capacity at its plants in Mexico and China, as well as for development of new processes and capacities. Some funds will also be used for debt repayment and working capital.